PACB vs POOL · rev $38.4M vs P/E 18, rev $5.31B
Pacific Biosciences of California (PACB) versus Pool Corporation (POOL) — a side-by-side from cached financials, not a winner call.
Pacific Biosciences of California (PACB) is a medical devices company listed on US.
Pool Corporation (POOL) is a industrial distribution company listed on NASDAQ.
Latest reported PACB revenue for 2025-09-30 was $38.4M. Net income was -$38.0M. Revenue was down 3.3% from 2025-06-30 to 2025-09-30. PACB currently screens at market cap $387.1M.
Latest reported POOL revenue for 2024-12-31 was $5.31B. Net income was $434.3M. Revenue was up 429.5% from 2023-12-31 to 2024-12-31. POOL currently screens at market cap $7.08B and trailing P/E 17.9.
PACB currently screens at market cap $387.1M. POOL currently screens at market cap $7.08B and trailing P/E 17.9.
Not investment advice. Open the PACB and POOL stock pages for the full models.
Not investment advice.